JP7391639B2 - 医薬製剤 - Google Patents

医薬製剤 Download PDF

Info

Publication number
JP7391639B2
JP7391639B2 JP2019221228A JP2019221228A JP7391639B2 JP 7391639 B2 JP7391639 B2 JP 7391639B2 JP 2019221228 A JP2019221228 A JP 2019221228A JP 2019221228 A JP2019221228 A JP 2019221228A JP 7391639 B2 JP7391639 B2 JP 7391639B2
Authority
JP
Japan
Prior art keywords
component
group
particles
content
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019221228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021091616A (ja
Inventor
遼平 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP2019221228A priority Critical patent/JP7391639B2/ja
Publication of JP2021091616A publication Critical patent/JP2021091616A/ja
Priority to JP2023196571A priority patent/JP7668863B2/ja
Application granted granted Critical
Publication of JP7391639B2 publication Critical patent/JP7391639B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019221228A 2019-12-06 2019-12-06 医薬製剤 Active JP7391639B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019221228A JP7391639B2 (ja) 2019-12-06 2019-12-06 医薬製剤
JP2023196571A JP7668863B2 (ja) 2019-12-06 2023-11-20 固形医薬製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019221228A JP7391639B2 (ja) 2019-12-06 2019-12-06 医薬製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023196571A Division JP7668863B2 (ja) 2019-12-06 2023-11-20 固形医薬製剤

Publications (2)

Publication Number Publication Date
JP2021091616A JP2021091616A (ja) 2021-06-17
JP7391639B2 true JP7391639B2 (ja) 2023-12-05

Family

ID=76312983

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019221228A Active JP7391639B2 (ja) 2019-12-06 2019-12-06 医薬製剤
JP2023196571A Active JP7668863B2 (ja) 2019-12-06 2023-11-20 固形医薬製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023196571A Active JP7668863B2 (ja) 2019-12-06 2023-11-20 固形医薬製剤

Country Status (1)

Country Link
JP (2) JP7391639B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023019149A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 錠剤
JP2023019148A (ja) * 2021-07-28 2023-02-09 エスエス製薬株式会社 一般用医薬品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009513512A (ja) 2003-07-09 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物
JP2011068645A (ja) 2009-08-31 2011-04-07 Lion Corp 内服固形製剤及びその製造方法
JP2014129239A (ja) 2012-12-28 2014-07-10 Lion Corp エトドラク含有固形製剤
JP2016030749A (ja) 2014-07-30 2016-03-07 ライオン株式会社 錠剤及びその製造方法
JP2021054728A (ja) 2019-09-27 2021-04-08 興和株式会社 医薬品

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009513512A (ja) 2003-07-09 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物
JP2011068645A (ja) 2009-08-31 2011-04-07 Lion Corp 内服固形製剤及びその製造方法
JP2014129239A (ja) 2012-12-28 2014-07-10 Lion Corp エトドラク含有固形製剤
JP2016030749A (ja) 2014-07-30 2016-03-07 ライオン株式会社 錠剤及びその製造方法
JP2021054728A (ja) 2019-09-27 2021-04-08 興和株式会社 医薬品

Also Published As

Publication number Publication date
JP2021091616A (ja) 2021-06-17
JP7668863B2 (ja) 2025-04-25
JP2024009126A (ja) 2024-01-19

Similar Documents

Publication Publication Date Title
JP6014044B2 (ja) 迅速分散顆粒、口腔内崩壊錠、および方法
JP6092936B2 (ja) 口腔内崩壊錠の製造方法
JP7668863B2 (ja) 固形医薬製剤
JP7209537B2 (ja) 固形医薬製剤
JP6090610B2 (ja) 錠剤の製造方法
JP5663238B2 (ja) 内服固形製剤及びその製造方法
JP6260736B1 (ja) 固形製剤
JP7657571B2 (ja) 医薬組成物
JP6708010B2 (ja) 内服固形製剤
JP7274825B2 (ja) 錠剤及びその製造方法
JP7377943B2 (ja) 固形製剤の製造方法
JP7607621B2 (ja) 錠剤の製造方法及び造粒粒子群
JP6140570B2 (ja) イブプロフェン含有錠剤及びその製造方法
JP2000063269A (ja) 固形製剤
JP2012046454A (ja) 内服用錠剤およびその製造方法
JP7419057B2 (ja) 錠剤及びコーティング錠
JP6552088B2 (ja) 造粒顆粒およびその製造方法と、錠剤およびその製造方法
JP7515253B2 (ja) 固形医薬製剤
JP7761480B2 (ja) 固形製剤
JP2024017669A (ja) 錠剤及びその製造方法
JP6180382B2 (ja) 錠剤及びその製造方法
JP2022132186A (ja) 医薬組成物
JP2003104896A (ja) アセチルサリチル酸含有口中崩壊性固形製剤
JP2015224228A (ja) 錠剤及びコーティング錠
JP2025023577A (ja) 固形製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220720

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230523

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230724

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231024

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231122

R150 Certificate of patent or registration of utility model

Ref document number: 7391639

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150